It was already shown that BCL-6 directly depends on pre-BCR signaling, where SYK inhibition reduced BCL-6 in the TCF3-PBX1 ALL cell line and patient-derived TCF3-PBX1 ALL cells [27]. This evidence concerns the gene BCL6 and acute lymphoblastic leukemia.